Europe Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type, By Product Type, By End User, By Country and Growth Forecast, 2022

List of Tables

The Europe Interventional Oncology Market would witness market growth of 5.8% CAGR during the forecast period (2022-2028).

The interventional oncology market is expected to increase in the future, as technological advancements have opened up a slew of new growth potential. Previously, most cancer patients had to go through a lengthy treatment process that included interdisciplinary treatments. This element posed a significant financial, emotional, and mental challenge for them. Interventional technology's super-selective tumour targeting and minimal injury to healthy tissues has demonstrated enormous potential to treat patients since technology has evolved. Interventional oncology is becoming more broadly utilized in cancer care due to technological enhancements, imaging developments, new contrast agents, and complicated navigation algorithms that have provided clinicians the accuracy to design therapies on the tumour.

Clinical trials of cancer medications have methodological guidelines and established main goals, however these are not always applicable to the clinical development of locoregional treatments and innovative medical devices. The present problem is to establish high-level clinical evidence for loco-regional therapies in order to determine patient advantages.

Lung cancer is the leading cause of mortality in Europe, responsible for roughly 20% of all cancer deaths and 3.2 million disability-adjusted life years lost each year. Lung cancer affects more than a quarter of those under the age of 60. Seven out of every eight patients die after five years of diagnosis, given current breakthroughs in surgery, chemotherapy, and radiotherapy. New findings in knowing the biology of lung cancer, on the other hand, have resulted in the development of potential novel targeted medicines. Lung cancer is caused mostly by smoking, which accounts for 90% of cases in men and 80% of cases in women. To reduce smoking and, as a result, the prevalence of lung cancer, consistent government effort is required.

Because many breast cancer cases in Europe are diagnosed early, many women may be able to receive breast saving surgery (BCT). Owing to the increase in the cases of breast cancer, lung cancer, liver cancer and prostate cancer across the world, the demand for numerous cancer treatments and solutions would spur across the region over the forecast period.

The Germany market dominated the Europe Interventional Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $190.5 million by 2028. The UK market is estimated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The France market would witness a CAGR of 6.6% during (2022 - 2028).

Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)

Scope of the Study

Market Segments covered in the Report:

By Cancer Type

Liver Cancer
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Bone Metastasis
Others

By Product Type

Embolization Devices
Ablation Devices
Support Devices

By End User

Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Boston Scientific Corporation
Teleflex, Inc.
Cook Medical, Inc. (Cook Group)
Medtronic PLC
Terumo Corporation
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Becton, Dickinson and Company
AngioDynamics, Inc.
Merit Medical Systems, Inc.
HealthTronics, Inc. (Altaris Capital Partners, LLC)

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Interventional Oncology Market, by Cancer Type
- 1.4.2 Europe Interventional Oncology Market, by Product Type
- 1.4.3 Europe Interventional Oncology Market, by End User
- 1.4.4 Europe Interventional Oncology Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Europe Interventional Oncology Market by Cancer Type

3.1 Europe Liver Cancer Market by Country
3.2 Europe Lung Cancer Market by Country
3.3 Europe Kidney Cancer Market by Country
3.4 Europe Breast Cancer Market by Country
3.5 Europe Prostate Cancer Market by Country
3.6 Europe Bone Metastasis Market by Country
3.7 Europe Others Market by Country

Chapter 4. Europe Interventional Oncology Market by Product Type

4.1 Europe Embolization Devices Market by Country
4.2 Europe Ablation Devices Market by Country
4.3 Europe Support Devices Market by Country

Chapter 5. Europe Interventional Oncology Market by End User

5.1 Europe Hospitals Market by Country
5.2 Europe Ambulatory Surgery Centers Market by Country
5.3 Europe Research & Academic Institutes Market by Country

Chapter 6. Europe Interventional Oncology Market by Country

6.1 Germany Interventional Oncology Market
- 6.1.1 Germany Interventional Oncology Market by Cancer Type
- 6.1.2 Germany Interventional Oncology Market by Product Type
- 6.1.3 Germany Interventional Oncology Market by End User
6.2 UK Interventional Oncology Market
- 6.2.1 UK Interventional Oncology Market by Cancer Type
- 6.2.2 UK Interventional Oncology Market by Product Type
- 6.2.3 UK Interventional Oncology Market by End User
6.3 France Interventional Oncology Market
- 6.3.1 France Interventional Oncology Market by Cancer Type
- 6.3.2 France Interventional Oncology Market by Product Type
- 6.3.3 France Interventional Oncology Market by End User
6.4 Russia Interventional Oncology Market
- 6.4.1 Russia Interventional Oncology Market by Cancer Type
- 6.4.2 Russia Interventional Oncology Market by Product Type
- 6.4.3 Russia Interventional Oncology Market by End User
6.5 Spain Interventional Oncology Market
- 6.5.1 Spain Interventional Oncology Market by Cancer Type
- 6.5.2 Spain Interventional Oncology Market by Product Type
- 6.5.3 Spain Interventional Oncology Market by End User
6.6 Italy Interventional Oncology Market
- 6.6.1 Italy Interventional Oncology Market by Cancer Type
- 6.6.2 Italy Interventional Oncology Market by Product Type
- 6.6.3 Italy Interventional Oncology Market by End User
6.7 Rest of Europe Interventional Oncology Market
- 6.7.1 Rest of Europe Interventional Oncology Market by Cancer Type
- 6.7.2 Rest of Europe Interventional Oncology Market by Product Type
- 6.7.3 Rest of Europe Interventional Oncology Market by End User

Chapter 7. Company Profiles

7.1 Boston Scientific Corporation
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
- 7.3.1 Company Overview
7.4 Medtronic PLC
- 7.4.1 Company overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent Strategies and Developments
  - 7.4.5.1 Product Launches and Product Expansions:
- 7.4.6 SWOT Analysis
7.5 Terumo Corporation
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Regional Analysis
- 7.5.5 Recent Strategies and Developments
  - 7.5.5.1 Partnerships, Collaborations and Agreements:
  - 7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental &Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 Europe Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 2 Europe Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 3 Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 4 Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 5 Europe Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 20 Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 21 Europe Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 28 Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 29 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 37 Germany Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 38 Germany Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 39 Germany Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 40 Germany Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 41 Germany Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 42 Germany Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 43 Germany Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 44 Germany Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 45 UK Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 46 UK Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 47 UK Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 48 UK Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 49 UK Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 50 UK Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 51 UK Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 52 UK Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 53 France Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 54 France Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 55 France Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 56 France Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 57 France Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 58 France Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 59 France Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 60 France Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 61 Russia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 62 Russia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 63 Russia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 64 Russia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 65 Russia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 66 Russia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 67 Russia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 68 Russia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 69 Spain Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 70 Spain Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 71 Spain Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 72 Spain Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 73 Spain Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 74 Spain Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 75 Spain Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 76 Spain Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 77 Italy Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 78 Italy Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 79 Italy Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 80 Italy Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 81 Italy Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 82 Italy Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 83 Italy Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 84 Italy Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of Europe Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 86 Rest of Europe Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 89 Rest of Europe Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 90 Rest of Europe Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 91 Rest of Europe Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of Europe Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 93 key Information - Boston Scientific Corporation
TABLE 94 key Information - Teleflex, Inc.
TABLE 95 key Information - Cook Medical, Inc.
TABLE 96 Key Information - Medtronic PLC
TABLE 97 Key Information - Terumo Corporation
TABLE 98 Key information - Johnson & Johnson
TABLE 99 Key information - Becton, Dickinson and Company
TABLE 100 Key Information - AngioDynamics, Inc.
TABLE 101 Key Information - Merit Medical Systems, Inc.
TABLE 102 Key Information - HealthTronics, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 SWOT Analysis: Boston Scientific Corporation
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson
FIG 5 Swot analysis: Becton, Dickinson and company

Europe Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type, By Product Type, By End User, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents